Dr. Hyon Choi received his rheumatology fellowship training at Massachusetts General Hospital and Harvard Medical School, and his master's and doctorate degrees in epidemiology from Harvard University. Dr. Choi has been a leading clinical rheumatologist and investigator with a primary focus on gout, rheumatoid arthritis, and psoriatic arthritis throughout his academic career, as reflected by his funding (National Institutes of Health [NIH] and industry), publications (over 200, including >60 gout-related peer-reviewed papers including those published in NEJM, JAMA, Lancet, Nat Genet, Ann Int Med, BMJ, Arch Int Med, Am J Med, Ann Rheum Dis, A&R), and reviewer activities for top journals and the NIH. The significance of Dr. Choi?s contributions has been widely accepted by the field, and his findings have been referenced by many articles as well as by the recent guidelines from the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR, 2012). His clinical and epidemiologic research has provided state-of-the-art evidence to inform the gout field, which is needed to move its guidelines from expert-consensus to an evidence-based approach.
Dr. Choi has been a leading physician investigator withprimary focus on gout and other inflammatory arthritic conditions throughouthis academic career. His research hasbeen funded by the NIH, Rheumatology Research Foundation, and industry,resulting in >200 publications (including those published in NEJM, JAMA,Lancet, Nat Genet, Ann Int Med, BMJ, Ann Rheum Dis, A&R). His research findings have been referenced bymany subsequent publications by others, including the recent guidelines fromthe European League Against Rheumatism and the